Citation Impact
Citing Papers
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial
2011 Standout
Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
2009 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Cardiotoxicity of anthracycline agents for the treatment of cancer: Systematic review and meta-analysis of randomised controlled trials
2010
Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies
2012 Standout
A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: A North American Brain Tumor Consortium study1
2006
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
Anthracycline-induced cardiotoxicity: course, pathophysiology, prevention and management
2007
Regimen-related toxicity and early posttransplant survival in patients undergoing marrow transplantation for lymphoma.
1989 StandoutNobel
Multicentre phase II study and pharmacokinetic analysis of irinotecan in chemotherapy-naïve patients with glioblastoma
2003
Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative.
1996 Standout
Inflammatory Myofibroblastic Tumor
2007 Standout
Fluorouracil in colorectal cancer--a tale of two drugs: implications for biochemical modulation.
1997
Marine natural products
1990 Standout
Role of AID in Tumorigenesis
2007 StandoutNobel
Irinotecan and its active metabolite, SN‐38: review of bioanalytical methods and recent update from clinical pharmacology perspectives
2009
Inflammatory myofibroblastic tumours: where are we now?
2007 Standout
Phase II study of ecteinascidin 743 in heavily pretreated patients with recurrent osteosarcoma
2003
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2014 Standout
Capillary electrophoretic drug monitoring of methotrexate and leucovorin and their metabolites
1998
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 Standout
Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma
1995 Standout
The performance of doxorubicin encapsulated in chitosan–dextran sulphate microparticles in an osteosarcoma model
2009
Comprehensive Echocardiographic Detection of Treatment-Related Cardiac Dysfunction in Adult Survivors of Childhood Cancer
2015
Survivors of childhood and adolescent cancer: life-long risks and responsibilities
2013 Standout
Neoadjuvant Treatment for Resectable Cancer of the Esophagus and the Gastroesophageal Junction: A Meta-Analysis of Randomized Clinical Trials
2003
Assessment of t(2;5)(p23;q35) Translocation and Variants in Pediatric ALK+ Anaplastic Large Cell Lymphoma
2004
Osteosarcoma treatment – Where do we stand? A state of the art review
2013 Standout
COMPARISON OF DOXORUBICIN CARDIOTOXICITY IN PEDIATRIC SARCOMA PATIENTS WHEN GIVEN WITH DEXRAZOXANE VERSUS AS CONTINUOUS INFUSION
2010
How to establish equivalence when data are censored: A randomized trial of treatments for B non‐Hodgkin lymphoma
1993
Treatment of high-grade lymphoid malignancies in adults
2001
Irinotecan: mechanisms of tumor resistance and novel strategies for modulating its activity
2002
Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: a pediatric oncology group study.
1996
Challenges, expectations and limits for nanoparticles-based therapeutics in cancer: A focus on nano-albumin-bound drugs
2013
Anthracycline associated cardiotoxicity in survivors of childhood cancer
2008
Hematopoietic Stem-Cell Transplantation
2006 Standout
Cancer treatment and survivorship statistics, 2012
2012 Standout
Analysis of anticancer drugs: A review
2011 Standout
Camptothecin and Podophyllotoxin Derivatives
2006
Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta
1999 Standout
LATE EFFECTS OF TREATMENT FOR WILMS TUMOR
2009
Urate-oxidase in the prevention and treatment of metabolic complications in patients with B-cell lymphoma and leukemia, treated in the Société Française d’Oncologie PédiatriqueLMB89 protocol
2002
Phase I studies of imatinib mesylate combined with cisplatin and irinotecan in patients with small cell lung carcinoma
2005
Neuroblastoma
2007 Standout
Reduced Expression of DNA Topoisomerase I in SF295 Human Glioblastoma Cells Selected for Resistance to Homocamptothecin and Diflomotecan
2007
Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents
2006
Delaying surgery with chemotherapy for osteosarcoma of the extremities
2004
Natural compounds for cancer treatment and prevention
2009 Standout
Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort
2009
5-Fluorouracil: mechanisms of action and clinical strategies
2003 Standout
Herb-Drug Interactions
2005 Standout
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2020 Standout
The anti-angiogenic basis of metronomic chemotherapy
2004 Standout
Lessons from the past: Opportunities to improve childhood cancer survivor care through outcomes investigations of historical therapeutic approaches for pediatric hematological malignancies
2011
Role of high-dose chemotherapy and autologous bone marrow transplantation in the treatment of lymphoma
1991
Larynx Preservation in Pyriform Sinus Cancer: Preliminary Results of a European Organization for Research and Treatment of Cancer Phase III Trial
1996 Standout
SFOP OS94: A randomised trial comparing preoperative high-dose methotrexate plus doxorubicin to high-dose methotrexate plus etoposide and ifosfamide in osteosarcoma patients
2007
Simultaneous determination of irinotecan (CPT-11) and SN-38 in tissue culture media and cancer cells by high performance liquid chromatography: Application to cellular metabolism and accumulation studies
2007
Childhood acute lymphoblastic leukemia
2002
Topoisomerase I inhibitors: camptothecins and beyond
2006 Standout
A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer
2003 Standout
Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group
2015
Nephron‐sparing surgery
2007
Tumour lysis syndrome: new therapeutic strategies and classification
2004 Standout
Cancer of the Ovary
2004 Standout
A Pilot Study of Idiotypic Vaccination for Follicular B-cell Lymphoma Using a Genetic Approach. University of Bristol, Bristol, United Kingdom
1997 StandoutNobel
Autologous hematopoietic stem cell transplantation in intermediate and high grade Non-Hodgkin's lymphoma: A review
1993
LATE EFFECTS OF TREATMENT FOR WILMS TUMOR
2009
Anthracyclines suppress pheochromocytoma cell characteristics, including metastasis, through inhibition of the hypoxia signaling pathway
2017 StandoutNobel
Childhood and adolescent cancer statistics, 2014
2014 Standout
Genome-wide cDNA microarray screening to correlate gene expression profiles with sensitivity of 85 human cancer xenografts to anticancer drugs.
2002
DNA Topoisomerase I Inhibitors: Chemistry, Biology, and Interfacial Inhibition
2009 Standout
Marine natural products
2015 Standout
The Tumor Lysis Syndrome
2011 Standout
Clinical pharmacokinetics and metabolism of irinotecan (CPT-11).
2001
High-dose busulfan and cyclophosphamide with autologous bone marrow transplantation support in advanced malignancies in children: a phase II study.
1986
Role of Cancer Treatment in Long-Term Overall and Cardiovascular Mortality After Childhood Cancer
2010
The Diagnosis and Medical Management of Advanced Neuroendocrine Tumors
2004
High-Dose Therapy and Autologous Bone Marrow Transplantation after Failure of Conventional Chemotherapy in Adults with Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
1987
Myeloablative Therapy for Follicular Lymphoma
1991
Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation, and marrow transplantation.
1987
Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma
2008 Standout
Silver Nanoparticles: Synthesis, Characterization, Properties, Applications, and Therapeutic Approaches
2016 Standout
The Risk of Determining Risk with Multivariable Models
1993 Standout
Cancer Therapy–Related Cardiac Dysfunction and Heart Failure
2016
Long-term Cardiovascular Toxicity in Children, Adolescents, and Young Adults Who Receive Cancer Therapy: Pathophysiology, Course, Monitoring, Management, Prevention, and Research Directions
2013
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
2015 Standout
Osteosarcoma: Current Treatment and a Collaborative Pathway to Success
2015 Standout
Comparison of 1,800 Laparoscopic and Open Partial Nephrectomies for Single Renal Tumors
2007 Standout
Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme
2007 Standout
Malformations, genetic abnormalities, and wilms tumor
2013
Phase II Trial of Irinotecan in Children With Refractory Solid Tumors: A Children's Oncology Group Study
2007
Decalactone Derivatives from Corynespora cassiicola, an Endophytic Fungus of the Mangrove Plant Laguncularia racemosa
2012
Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
2012 Standout
The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
2008 Standout
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
Global burden of heart failure: a comprehensive and updated review of epidemiology
2022 Standout
American Society of Clinical Oncology Clinical Evidence Review on the Ongoing Care of Adult Cancer Survivors: Cardiac and Pulmonary Late Effects
2007
Works of F Pein being referenced
Radiation dose and long term risk of cardiac pathology following radiotherapy and anthracyclin for a childhood cancer
2006
High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: results from the French Pediatric Oncology Society of a randomized trial of 216 children.
1991
Etoposide in relapsed or refractory Wilms' tumor: a phase II study by the French Society of Pediatric Oncology and the United Kingdom Children's Cancer Study Group.
1993
Cardiac abnormalities 15 years and more after adriamycin therapy in 229 childhood survivors of a solid tumour at the Institut Gustave Roussy
2004
A phase III study of recombinant interleukin-2, 5-fluorouracil and leucovorin versus 5-fluorouracil and leucovorin in patients with unresectable or metastatic colorectal carcinoma
1995
Reduction of postoperative chemotherapy in children with stage I intermediate-risk and anaplastic Wilms' tumour (SIOP 93-01 trial): a randomised controlled trial
2004
Childhood anaplastic large cell lymphoma Ki‐1/CD30: Clinicopathologic features of 19 cases
1994
Phase I trial and pharmacological study of a 3-hour paclitaxel infusion in children with refractory solid tumours: a SFOP study
2001
Prognosis of Children with Malignant Pheochromocytoma
1999
Phase II study of cytarabine and etoposide in children with refractory or relapsed non-Hodgkin's lymphoma: a study of the French Society of Pediatric Oncology.
1990
A phase I study of intravenous liposomal daunorubicin (DaunoXome) in paediatric patients with relapsed or resistant solid tumours
2006
Ifosfamide and etoposide in childhood osteosarcoma. A phase II study of the french society of paediatric oncology
1997
Preclinical development of camptothecin derivatives and clinical trials in pediatric oncology
1998
High-dose therapy and autologous bone marrow transplantation in partial remission after first-line induction therapy for diffuse non-Hodgkin's lymphoma.
1988
A Phase I Study of Irinotecan As a 3-Week Schedule in Children With Refractory or Recurrent Solid Tumors
2003
Metabolism of irinotecan (CPT-11) by CYP3A4 and CYP3A5 in humans.
2000
High-dose polychemotherapy with autologous bone marrow transplantation in children with relapsed lymphomas.
1984